Literature DB >> 14305957

THE MECHANISM OF HYPOALBUMINEMIA IN RHEUMATOID ARTHRITIS.

P WILKINSON, R JEREMY, F P BROOKS, J L HOLLANDER.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; ARTHRITIS, RHEUMATOID; BLOOD PROTEIN DISORDERS; DRUG THERAPY; PHYSIOLOGY; PROTEIN METABOLISM; SERUM ALBUMIN; SERUM ALBUMIN, RADIO-IODINATED

Mesh：

Substances：

Year:  1965        PMID： 14305957     DOI： 10.7326/0003-4819-63-1-109

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

2.  Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.

Authors:  F A Van den Ouweland; F W Gribnau; Y Tan; C A Van Ginneken; L B Van de Putte
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

3.  Albumin metabolism in rheumatoid arthritis.

Authors:  F C Ballantyne; A Fleck; W C Dick
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

4.  Rheumatoid arthritis: extra-articular manifestations. II.

Authors:  F D Hart
Journal:  Br Med J       Date:  1970-06-27

5.  Effect of Disease-Related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2017-02-28       Impact factor: 3.922

6.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

7.  Aspirin-induced hepatic dysfunction in a patient with adult rheumatoid arthritis.

Authors:  D A Saltzman; E P Gall; S F Robinson
Journal:  Am J Dig Dis       Date:  1976-09

8.  Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.

Authors:  Mengyuan Liu; Yi Huang; Lei Hu; Guoping Liu; Xueping Hu; Dongxu Liu; Xiaosong Yang
Journal:  BMC Biotechnol       Date:  2012-09-25       Impact factor: 2.563

9.  A novel tumor targeting drug carrier for optical imaging and therapy.

Authors:  Rui Li; Ke Zheng; Ping Hu; Zhuo Chen; Shanyong Zhou; Jincan Chen; Cai Yuan; Song Chen; Wei Zheng; En Ma; Fengling Zhang; Jinping Xue; Xueyuan Chen; Mingdong Huang
Journal:  Theranostics       Date:  2014-03-24       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.